Thirty Years of Creatine Trials, and Only Two Ever Checked Whether It Reached the Brain
Creatine is the most studied supplement in sports nutrition, and lately it is being sold hard for something else entirely: memory, mood and brain health. I went looking for the trials that would actually back that up, and found a genuinely surprising gap instead.
- A meta research study reviewed 343 randomized creatine trials published between 1994 and 2023 and found only 11 percent ever mention whether the creatine was actually absorbed, and just 2 trials set out to measure creatine levels in the brain specifically.
- Creatine monohydrate raises brain creatine by roughly 5 to 15 percent, compared with 20 to 40 percent in muscle, likely because the blood brain barrier has far fewer of the transporters needed to let it through.
- The study's authors say plainly that marketing claims about newer, more bioavailable creatine formulations are not adequately supported by the trial evidence that actually exists.
- This does not prove creatine fails to reach the brain. It proves the trials that would answer that question have mostly never been run, which is a good reason to keep the cheap, well studied monohydrate rather than pay up for an unproven claim.
Thirty years of trials, and almost nobody checked the plumbing
Researchers at the University of Split, working with colleagues at Jagiellonian University Medical College in Krakow, went back through 357 published reports covering 343 randomized controlled trials of oral creatine, spanning 1994 through 2023. What they were looking for was not whether creatine worked. It was whether the trials ever checked if the creatine actually got where it was supposed to go, a property researchers call bioavailability.
The results, published in the journal Nutrients, are stark. Only 38 reports, about 11 percent, mention bioavailability at all, and mostly only in passing, in a discussion section, rather than as something the trial actually measured. Another 53 reports, 15.5 percent, do not even specify which chemical form of creatine the participants took. Just 4 trials, 1.2 percent, made any deliberate attempt to improve absorption, such as instructions to take the dose with food or a carbohydrate. And only 5 trials in the entire 343 ever compared two different creatine formulations head to head, with just 3 of those discussing bioavailability at all, undermined by dosing that was not matched on actual creatine content between arms.
- 343
- Randomized creatine trials reviewed, published 1994 to 2023
- 11%
- Of those trials even mention whether the creatine was absorbed
- 15.5%
- Do not even say which chemical form of creatine was used
- 5 to 15%
- How much creatine monohydrate raises brain creatine, versus 20 to 40% in muscle
Shixart1985CC BY 2.0
Most tellingly, only 2 of the 343 trials set out specifically to raise creatine levels in the brain. Everything else studied muscle, blood or general outcomes. The organ that today's marketing is most excited about is the one that thirty years of research almost entirely ignored.
Why the brain is the harder target
There is a real biological reason the brain deserves separate attention here. Creatine monohydrate raises brain creatine by only about 5 to 15 percent, compared with 20 to 40 percent in muscle, and the leading explanation involves the blood brain barrier, the protective layer that limits what can pass from the bloodstream into brain tissue. It appears to have relatively few of the transporter proteins, specifically SLC6A8, that let creatine cross through easily. Getting creatine into muscle is a comparatively simple problem the supplement industry solved decades ago. Getting a meaningfully higher dose into the brain is a much harder one, and it is not a problem thirty years of trials were actually built to solve.
That gap matters right now because the marketing has moved faster than the science. In just the past few weeks, brain focused creatine claims have shown up in sparkling protein drinks, clear protein and creatine combinations, and a wave of new product launches explicitly pitching creatine as a cognitive support ingredient. The paper's authors are direct about what that marketing can and cannot lean on. Claims that newer, enhanced bioavailability creatine formulations work better are not, in their words, adequately supported by clinical trial evidence.
Honest caveat
This is a study about studies. It measures how well the existing trials were designed and reported, not whether creatine actually reaches or helps the brain. It does not show that creatine fails the brain, and it does not show that newer formulations do not work. It shows that the trials that would answer either question were almost never run. That is absence of evidence, not evidence of absence, and it matters here specifically. Two further limits are worth knowing. The literature search that fed this review ended March 1, 2024, so it by construction misses roughly two years of the current creatine for cognition research wave, some of which may already be closing this gap. And it is a single, unreplicated meta research study, which is part of why it is graded B rather than higher here. One more thing worth getting right: an early trade write up of this paper stated its authors recommend non equimolar dosing in future comparison trials. That is backwards. The paper itself recommends equimolar dosing, meaning trial arms matched on actual creatine content, precisely because non equimolar comparisons are what undermined the handful of head to head trials that already exist.
the trials that would answer either question were almost never run
What this means for you
If you take creatine, or are thinking about starting, this paper is a genuinely useful reason not to pay a premium for a newer, more bioavailable or brain optimized version. Plain creatine monohydrate is what 80.2 percent of the entire evidence base is actually built on, it is the cheapest form on the shelf, and it is the one thing in this whole picture that thirty years of trials have actually tested at scale. The comparison trials that would justify paying more for something else have not been run, with three narrow exceptions in three decades. If brain health specifically is your goal, it is fair to stay curious and watch this space rather than assume either that creatine helps your brain the way it helps your muscles, or that it does not. The honest answer today is that almost nobody has actually checked.
Primary sources
Common questions
Does this study prove creatine does not work for the brain?
No. It is a study about studies, meaning it measures how well the existing trials were designed and reported, not whether creatine works. It does not show creatine fails to reach the brain and it does not show that newer formulations do not work. It shows that almost none of the trials were built to answer either question. Absence of evidence is not the same thing as evidence of absence.
Should I pay more for an advanced or enhanced bioavailability creatine?
Based on what actually exists in the trial record, there is not much to support paying a premium for it. The review found only 5 of 343 trials ever compared two creatine forms head to head, and the paper's authors state directly that claims of improved bioavailability for newer formulations are not adequately supported by clinical trial evidence. Plain creatine monohydrate is what 80 percent of the entire evidence base is actually built on.
Why would the brain be harder for creatine to reach than muscle?
The leading explanation is that the blood brain barrier, the protective layer around brain tissue, has relatively few of the transporter proteins that let creatine cross from the blood into muscle easily. That is thought to be why creatine monohydrate raises brain creatine by roughly 5 to 15 percent, compared with 20 to 40 percent in muscle, though this comparison comes from earlier studies the new review cites rather than a finding of the review itself.
Stay Curious.
Better health isn't found in a single article. It's built through curiosity, evidence, and small discoveries over time. Join thousands exploring longevity, gut health, recovery, nutrition, and the tools that truly make a difference.